Next Article in Journal
Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics
Previous Article in Journal
Integrin-Mediated Delivery of Drugs and Nucleic Acids for Anti-Angiogenic Cancer Therapy: Current Landscape and Remaining Challenges
Article Menu
Issue 4 (December) cover image

Export Article

Open AccessArticle
Bioengineering 2018, 5(4), 77;

Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank

Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Ephessiou Street, 11527 Athens, Greece
Immunology Division, General Hospital of Athens “Alexandra”, Lourou Street, 11528 Athens, Greece
Department of Hematology and Bone Marrow Transplantation, School of Medicine, National and Kapodistrian University of Athens, 17, Agiou Thoma Street, 11527 Athens, Greece
Author to whom correspondence should be addressed.
Received: 10 August 2018 / Revised: 13 September 2018 / Accepted: 19 September 2018 / Published: 21 September 2018
Full-Text   |   PDF [2556 KB, uploaded 21 September 2018]   |  


Background: During pregnancy, the maternal-fetal contact may lead to the development of tolerance against the maternal human leukocyte antigen (HLA) that is not inherited by the fetus. These non-inherited maternal antigens (NIMAs) define acceptable HLA mismatches; therefore, the number of HLA phenotypes that are suitable matches for patients who need a hematopoietic stem cell transplant could be increased. Cord blood unit (CBU) transplantations to patients mismatched for a HLA loci, but similar to the ΝΙΜAs of the CBU, have a prognosis similar to 6/6-matched ones. Methods: The Hellenic Cord Blood Bank (HCBB) identified the maternal HLA of 380 cord blood donors, specifying the NIMA haplotypes of the related cryostored CBUs. Results: The HCBB extended the pool of HLA phenotypes through the generation of unique virtual phenotypes (VPs). A “VP database” was set up, using Microsoft Office—Access™, in order to provide NIMA-matched CBUs for potential recipients. The effectiveness of VPs’ matching was tested in 80 Greek patients. Conclusion: This methodology may contribute to the increase of the number of available CBUs for patients, in the case where there is no available CBU, or in case an additional one is needed. Through this method, the CBUs could be used faster and more effectively, rather than being cryostored for long periods of time. View Full-Text
Keywords: cord blood; NIMA; Hellenic Cord Blood Bank; CBU transplantation cord blood; NIMA; Hellenic Cord Blood Bank; CBU transplantation

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Panagouli, E.; Dinou, A.; Mallis, P.; Michalopoulos, E.; Papassavas, A.; Spyropoulou-Vlachou, M.; Meletis, J.; Angelopoulou, M.; Konstantopoulos, K.; Vassilakopoulos, T.; Stavropoulos-Giokas, C. Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank. Bioengineering 2018, 5, 77.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Bioengineering EISSN 2306-5354 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top